Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPTRANE: Qutenza versus pregabalin for early neuropathic pain after breast cancer surgery
2018-003559-39Phase 3Completed
- Sponsor
- Institut Cancérologique de l'Ouest
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Neuralgia and postoperative neuropathic pain (PONP) comparing Qutenza (capsaicin 8% patch) with Pregabalin oral treatment (2 arms). Primary endpoint: Change in neuropathic pain at 2 months. Started Oct 2018; status: completed.
02
Drugs
capsaicinpregabalin
03
Conditions
Neuralgiapostoperative neuropathic pain (PONP)
Beyond the preview
Go deeper on 2018-003559-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003559-39.